Virios Therapeutics, Inc. (VIRI) Financials

VIRI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 4.2 million 358548
2023-09-30 5.2 million 487144
2023-06-30 5.2 million 520032
2023-03-31 6.5 million 549290

VIRI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.5 million 148306
2023-09-30 -960454 148305
2023-06-30 -742414 161664
2023-03-31 -1.7 million 161697

VIRI Net Income

No data available :(

VIRI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 3.3 million - -
2023-09-30 4.8 million - -
2023-06-30 4.6 million - -
2023-03-31 5.3 million - -

VIRI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 19.3 million
2023-09-30 19.1 million
2023-06-30 18.4 million
2023-03-31 18.3 million

VIRI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 298320 839805 1
2023-09-30 - 374200 900089 -
2023-06-30 - 557843 919374 -
2023-03-31 - 497714 1.1 million -

VIRI Cost of Revenue

No data available :(

VIRI

Price: $0.47

52 week price:
0.28
2.42

Earnings Per Share: -0.28 USD

P/E Ratio: -2.54

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 306080

Market Capitalization: 9.2 million

Links: